ECRI Blog

Health Technology Assessments Vital to Payers for Defensible Coverage Determinations

In today's healthcare environment, payers are under increasing pressure to make new and updated medical policy determinations as quickly and cost-effectively as possible.

Health technology assessments (HTAs) can provide a synthesis of the relevant evidence-based clinical literature to enable payers to make informed decisions about whether or not to cover a new medical technology. In this article, we'll explore the importance of HTAs for payers in developing strong, defensible coverage decisions.

What is a health technology assessment?

A HTA is a systematic evaluation of a technology's efficacy, safety, and cost-effectiveness. There are various HTA methods, but all HTAs share a common goal: to provide a fair and objective evaluation of a technology's benefits and risks based on the published clinical literature. This information can be used to help policymakers, clinicians, and healthcare leadersmake informed decisions about whether or not to adopt a new technology. 

Read More

Topics: Patient Safety

Controversial New Study on Medical Masks versus N95 Respirators for COVID Prevention in Healthcare Workers

We noted with great interest the study by Loeb et al., published in the December 2022 issue of Annals of Internal Medicine, as well as a helpful commentary and various reactions to the findings. In this commentary, we discuss the notion of a “non-inferiority” trial and address several concerns.

What are non-inferiority trials?

When an effective treatment is expensive or inconvenient, we might consider a reasonable alternative that is cheaper and/or more convenient. How much reduction in effectiveness is acceptable? Research studies can be designed as “non-inferiority” trials that, critically, set a numerical threshold for how much reduced effectiveness one is willing to tolerate in exchange for the known benefits of reduced cost and/or convenience. If the study can rule out the possibility of an effectiveness reduction as large as the numerical threshold, then the cheaper treatment can be deemed “non-inferior.” Ideally, the threshold is not based on one research team’s opinion, but rather on empirical data from those who would experience both the reduced benefits and better cost/harm profile. Even if data-based, the answer is a middle-of-the-road judgment with no objectively correct answer, as different people would set higher or lower thresholds.

Read More

Topics: Patient Safety

Advancing Patient Safety Through Better Designs or Processes: Top 10 Health Tech Hazards Part 2

This is part two of a two-part blog.

A nurse's aide, when transferring a mother in labor to the delivery room, turned off the infusion pump delivering Pitocin, a drug administered intravenously to accelerate contractions. The aide removed the infusion set from the pump without first closing the manual clamp on the line. A free-flow infusion occurred, and the mother received nearly 35 times the prescribed amount of drug. The infant suffered organ damage and pneumonia and died four days later.

This incident happened in 1991.

A decade earlier, ECRI had warned about the dangers of IV free flow in a 1982 evaluation of infusion controllers. Free-flow, or unrestricted gravity flow, refers to the uncontrolled delivery of an infusion to a patient when a controlled or metered delivery was intended. Depending on the drug being administered, IV free flow can lead to death or serious patient harm. That's why the test criteria for our 1982 evaluation specified that infusion devices should provide safeguards to prevent uncontrolled flow.

Fast-forward to the decade after that incident. By the early 2000s, many infusion pumps included an effective free-flow protection mechanism to guard against this hazard. Today, such mechanisms are a standard safety feature.

But how many patients suffered harm in the meantime?

It's with that question in mind that we issued a challenge to industry within the pages of our Hazards report. The report identifies 10 health technology hazards that ECRI's experts believe warrant priority attention. In ECRI's view, several of the hazards listed could be mitigated—and possibly eliminated—by improved device designs or manufacturing quality processes. We encourage industry to rise to that challenge.

Read More

Topics: Patient Safety

Top 10 Health Tech Hazards for 2023: A Tool to Reduce Preventable Harm

This is part one of a two-part blog.

Reducing preventable harm is at the core of ECRI’s mission, and has been for more than 50 years. Since the publication of the first issue of the Health Devices journal in 1971, ECRI has served as an information clearinghouse for hazards and deficiencies in medical devices. We collect and analyze reports of device-related problems, identify root causes, and develop practical recommendations to prevent future occurrences and prevent harm.

ECRI’s annual Top 10 Health Technology Hazards report is one tool we develop to help members of the healthcare community participate in that mission. The report informs frontline healthcare workers, administrators, clinical engineers, IT professionals, medical device manufacturers, patients, regulatory bodies, and others about device-related hazards, and it empowers them to address those issues to make healthcare safer.

Read More

Topics: Patient Safety

Strategies to Help Improve Flu Vaccine Access for People of Color

Influenza (flu) is a contagious respiratory illness caused by various viruses. It can cause mild to severe illness, and at times can even lead to death. Flu season started earlier than usual this season, and it has been joined by RSV and ongoing COVID-19 to form the “tridemic.” 

We know that getting the flu vaccine is the best defense against getting the flu; and even if a vaccinated person does contract the flu, the vaccine can significantly reduce symptoms. However not every eligible person is getting vaccinated, especially in communities of color.

The Centers for Disease Control and Prevention (CDC) has reported that inequities in access to the flu vaccine and misinformation about the vaccine can contribute to lower vaccination rates in minority communities.

With a vaccination rate of only 43% during the 2021–2022 flu season, Black, Hispanic, and American Indian/Alaska Native adults were more likely to get the flu and more likely to be hospitalized due to the flu. In fact, when the CDC examined hospitalizations caused by the flu, hospitalization rates were 80 percent higher among Black adults than white adults.

Read More

Topics: Patient Safety

Don't Skip the Flu Shot This Year: 3 Reasons to Get One—Even If You Usually Don't

As always, influenza (flu) is in the news this time of year, along with recommendations that all eligible individuals get vaccinated against it. As many as 50% of eligible people typically skip a flu shot, and this year the temptation to skip may be stronger than usual.

After facing COVID-19, some people may be quick to dismiss the relatively much smaller risk posed by the flu, and persisting disinformation around COVID-19 vaccines casts a shadow on other vaccines. Several factors, however, suggest that this year's flu season comes with new risks and the potential for a new public health crisis. 

Read More

Topics: Patient Safety

3 Tips to Help Prepare Your Healthcare Facility for the Tridemic—RSV, Flu, and COVID

Posted by Edward Nuber, Director of Marketing, ECRI on Dec 13, 2022

The tridemic is hereare you ready? By taking steps to understand the tridemic, and the effects it’s having on healthcare, your organization can better prepare for and manage the likely increase in utilization of emergency departments, pediatric practices, and inpatient hospital stays. 

What is the tridemic?

The tridemic is the unofficial name that has been given to the rise in cases of three different illnesses—influenza (the flu), COVID-19, and respiratory syncytial virus (RSV). Flu and RSV cases comprise the majority of circulating illnesses, as COVID numbers have been stable recently.

Alone, each of these illnesses can tax an already strained healthcare system. Together, they have the potential to cripple healthcare infrastructure due to worsening illness severity and sheer number of cases. 

Rising numbers in cases have been reported in Canada and in half of the United States. As the holidays and colder weather quickly approach, and with them a likely increase in indoor celebrations, experts fear that tridemic numbers will continue to rise. 

Read More

Topics: Patient Safety

5 Things Clinicians Should Know About the Complex World of Genetic Testing

Selecting the appropriate genetic test can be daunting, and busy clinicians can be hard pressed to stay up to date regarding the rapidly-evolving landscape of genomic medicine. They need to know what a test does, what diseases or conditions a test targets, what tests have evidence showing a benefit to patient management, and what tests are covered by payers. ECRI’s Genetic Test Assessment service focuses on assessing clinical evidence on genetic tests and deciphering a test’s intended purpose and methodology.

Below are some frequently asked questions from healthcare professionals who use ECRI to guide utilization of genetic testing. 

Read More

Topics: Patient Safety

8 Steps to Address Racial Bias in Healthcare

Woman sitting on sofa at therapy with doctor taking notesECRI this year named Bias and Racism in Addressing Patient Safety as number three on its annual list of Top 10 Patient Safety Concerns. Racial and ethnic disparities have been well documented, and while some progress has been made, the problem is pervasive, persistent, and damaging.

These disparities affect:

  • Patient access to care
  • Patient safety
  • Quality of care and clinical outcomes
  • The frequency and consistency with which reports of adverse events are filed
  • The level of responsiveness when adverse events are reported
  • Patient health, well-being, and life expectancy

Research shows that patients who are members of racial and ethnic minority groups experience barriers that limit their access to care, and affect the quality of their care, more frequently than non-minorities; this includes having an increased risk of being uninsured or underinsured, lacking access to care, and experiencing worse health outcomes for conditions that are treatable and even preventable. 

Read More

Topics: Patient Safety

The Most Common Hospital Accidents and How To Avoid Them

Posted by Christopher Schabowsky, PhD, CCE on Oct 25, 2022

When working in healthcare, it is important to understand what types of accidents might your patients encounter. How can you work to dramatically reduce accidents and foster a greater culture of safety? Here, we'll examine some of the most common hospital accidents, how you can avoid them, and how ECRI can support you in your journey to better healthcare.

Read More

Topics: Patient Safety

Related Resources

ECRI Now provides unique insights on pressing healthcare issues.  In each episode, ECRI’s subject matter experts share their experience in relationship to the latest healthcare news.

Listen to our podcast on
    Apple | Google | Spotify 

Subscribe for Email Updates

Recent Posts